The promise and challenges of pharmacogenomics in psychiatry
Pharmacogenomics (PGx) is an expanding field within precision medicine that is poised to play a crucial role in optimising patient outcomes, particularly in the realm of psychiatry. The remission rate for the initial antidepressant prescribed in the Sequenced Treatment Alternatives to Relieve Depre...
Saved in:
Main Authors: | Elaine Ah Gi Lo, Yi Min Wan, Cyrus Su Hui Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Medicine Singapore
2024-12-01
|
Series: | Annals, Academy of Medicine, Singapore |
Online Access: | https://annals.edu.sg/the-promise-and-challenges-of-pharmacogenomics-in-psychiatry/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomics in psychiatry: Practice recommendations from an Asian perspective (2024)
by: Shih Ee Goh, et al.
Published: (2024-12-01) -
Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01) -
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
by: Sharon Cresci
Published: (2008-01-01) -
Editorial: Women in psychiatry 2023: aging psychiatry
by: Elizabeta B. Mukaetova-Ladinska, et al.
Published: (2025-02-01) -
Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)